|
|
||||||||
Departments of Medicine and of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110
| |
ABSTRACT |
|---|
|
|
|---|
Exercise increases the expression of lipoprotein lipase (LPL) and GLUT-4 in skeletal muscle. Intense exercise increases catecholamines, and catecholamines without exercise can affect the expression of both LPL and GLUT-4. To test the hypothesis that adrenergic-receptor signaling is central to the induction of LPL and GLUT-4 by exercise, six untrained individuals [age 28 ± 4 (SD) yr, peak oxygen uptake 3.6 ± 0.3 l/min] performed two exercise bouts within 12 days. Exercise consisted of cycling at ~65% peak oxygen uptake for 60 min with (block trial) and without (control trial) adrenergic-receptor blockade. Exercise intensity was the same during the block and control trials. Plasma catecholamine concentrations were significantly higher and heart rates were significantly lower during the block trial compared with the control trial, consistent with known effects of adrenergic-receptor blockade. However, blockade did not prevent the induction of either LPL or GLUT-4 proteins assayed in biopsies of skeletal muscle. LPL was significantly increased by 170-240% and GLUT-4 was significantly increased by 32-51% at 22 h after exercise compared with before exercise during both the control and block trials. These findings provide evidence that exercise increases muscle LPL and GLUT-4 protein content via signals generated by alterations in cellular homeostasis and not by adrenergic-receptor stimulation.
catecholamines; lipid metabolism; glucose transport;
-blocker;
-blocker
| |
INTRODUCTION |
|---|
|
|
|---|
CARBOHYDRATES AND FATTY ACIDS are the main fuel sources utilized during exercise and during recovery from exercise. Lipoprotein lipase (LPL), the rate-limiting factor for the metabolism of triglyceride-rich lipoproteins, and GLUT-4, the major glucose transporter of skeletal muscle, are critical for the acquisition of fatty acids and glucose during and after exercise. The uptake of substrates after exercise replenishes energy stores in preparation for the next bout of exercise and provides fuel for muscle repair and other recovery functions (15).
Exercise depletes high-energy phosphates in muscle and increases the concentration of AMP, causing activation of AMP-activated protein kinase (AMPK). Activation of AMPK probably mediates translocation of GLUT-4 into the sarcolemma with exercise (9, 20). Exercise also increases mRNA and protein levels of both GLUT-4 and LPL in skeletal muscle within 18 h after a bout of exercise (29, 31, 32). The signaling events leading to enhanced expression (probably by activation of transcription) of the GLUT-4 and LPL genes have not yet been identified. Catecholamines increase as a function of exercise intensity (6) and interact with G protein-coupled cell-surface receptors. Both catecholamines and exercise are known to increase intracellular concentrations of cAMP, a signaling molecule implicated in the expression of LPL in skeletal and cardiac muscle (3-5, 27).
Although catecholamines stimulate LPL expression in resting muscle (3-5, 27), it is unclear whether the striking rise in catecholamines seen with exercise contributes to exercise induction of LPL. It is also not known whether catecholamines increase GLUT-4 expression. In this paper, we specifically address the question of whether the increase in skeletal muscle LPL and GLUT-4 protein after exercise is caused by adrenergic-receptor stimulation during exercise. To answer this question, we measured skeletal muscle LPL and GLUT-4 protein content after a single bout of exercise performed in the presence and absence of adrenergic-receptor blockade.
| |
METHODS |
|---|
|
|
|---|
Subjects. Subjects were healthy, active, but untrained individuals who regularly performed recreational physical activities. Body composition was estimated from hydrostatic weight. The study was approved by the Washington University Human Studies Committee. Informed consent was obtained from each subject.
Oxygen uptake.
A continuous cycle ergometer test was performed by each individual to
determine peak oxygen uptake
(
O2 peak). The protocol
consisted of cycling at 100, 150, and 200 W for 3 min per
exercise intensity, followed by 25 W increments every 1 min until
exhaustion. An automated on-line system was used to collect and analyze
expired air throughout the exercise test (Max-1, Physio-Dyne Instrument, Farmingdale, NY). Each subject met at least two of the
following criteria during the
O2 peak
protocol: plateau in oxygen consumption with increasing work rate,
heart rate within 10 beats/min of age-predicted maximal heart rate, and
a respiratory exchange ratio exceeding 1.11.
Exercise trials. Two exercise trials, one with and one without adrenergic-receptor blockade, were completed within a 7- to 12-day period. The order of the trials was randomized. Subjects did not exercise the day before each trial.
Adrenergic-receptor blockade was achieved with the nonselective
-blocker phenoxybenzamine (Dibenzyline, SmithKline Beecham Pharmaceuticals) and the nonselective
-blocker propranolol (Inderal, Ayerst Laboratories). Phenoxybenzamine is an oral medication. It was not possible to obtain phentolamine, an intravenous
-blocker, for this study. At the time of these experiments, phentolamine use in
the United States was limited to medical emergencies because of
manufacturing problems. As previously described (36),
-blockade with phenoxybenzamine was started 3 days before the
exercise trial at a dose of 10 mg by mouth four times per day
(day 1). The dosage was progressively increased to 20 mg
four times per day (day 2) and to 30 mg four times per day
(day 3), and then subjects ingested 40 mg 1.5 h before
the exercise bout on day 4. For
-blockade (24), subjects received a primed (143 µg/kg) continuous
intravenous infusion of propranolol, beginning 30 min before the
exercise bout. At the start of exercise, the dosage was decreased to
1.4 µg · kg
1 · min
1, and
infusion of propranolol was continued at this rate until 15 min after
the completion of exercise.
On each exercise day, a blood sample was obtained in the morning
after a 12-h fast. A vastus lateralis muscle biopsy was performed. Forty-five minutes later, subjects exercised for 1 h on an
electrically braked cycle ergometer at ~65%
O2 peak. Oxygen uptake was measured at
15 min-intervals during the exercise bout, and power output was
adjusted to maintain ~65%
O2 peak.
After the exercise bout, subjects rested in bed for the next 22 h
in the Washington University General Clinical Research Center. Blood samples were obtained periodically from an indwelling catheter, and
muscle biopsies were performed 8 and 22 h after exercise. Diets
during the protocol were standardized and identical for the two trials.
Muscle biopsies.
Biopsies were performed as previously described
(31). After the initial biopsy, the contralateral leg was
used for the second biopsy. The third biopsy was performed 3 cm distal
to the site of the initial biopsy. The biopsies for the second trial
were performed in the same sequence as the first trial at sites 3 cm distal to the initial biopsies. Muscle samples were immediately cleansed with saline, trimmed of any visible fat, blotted dry, and
frozen in liquid nitrogen. Samples were then stored at
80°C for
subsequent analysis. Muscle samples from all time points were analyzed
for LPL and GLUT-4 protein content by Western blotting as described
previously (30, 31). Antibody-bound protein
was visualized by using enhanced chemiluminescence (Amersham/Pharmacia Biotech). Protein bands were quantified by densitometry. Data are
expressed per protein content. As shown previously (32), acute exercise has no detectable effect on the control protein myosin
when this assay is used.
Blood sampling and analysis.
A polyethylene catheter was inserted into an antecubital vein in the
morning before the initial biopsy and kept patent with saline. Blood
samples were obtained from the subjects before the initial biopsy,
immediately before exercise, at 30 min of exercise, and just before
completion of exercise. In addition, blood samples were obtained every
30 min for the first 2.5 h after exercise and then every 1 h
for the next 6 h. Samples were subjected to centrifugation (15 min
at 2,000 g), and the supernatant was collected and stored at
80°C until subsequent analyses. Samples were analyzed for insulin
(25), catecholamines (33), leptin
(23), glucose (Sigma Chemical, St. Louis, MO), and
nonesterified fatty acids (Waco Chemicals, Dallas TX). Lipid and
lipoprotein levels were measured after a 12-h fast in accordance with
the Centers for Disease Control lipid standardization program.
Statistics. Muscle protein content of LPL and GLUT-4 as well as plasma samples were analyzed by using two-way repeated-measures analysis of variance. A Tukey post hoc test was performed when the analysis of variance revealed significant differences.
| |
RESULTS |
|---|
|
|
|---|
Subject characteristics are shown in Table
1. Exercise intensities during
the two trials were not significantly different (Table
2). Heart rates were significantly lower
during exercise for the block trial compared with the control trial
(Table 2). Plasma epinephrine (Fig.
1A) and norepinephrine (Fig.
1B) concentrations were significantly higher during exercise
for the block trial compared with the control trial, an expected result
because receptor blockade interferes with normal catecholamine
clearance. Lower heart rates and higher catecholamine levels during the
block trial indicate that adrenergic-receptor blockade was successful.
|
|
|
Muscle LPL protein content.
Skeletal muscle biopsies were performed before and at 8 and 22 h
after the exercise bout for both trials. Muscle was assayed for LPL and
GLUT-4 protein content. The absolute amounts of muscle tissue LPL and
GLUT-4 were variable between individuals. Therefore, LPL and GLUT-4
signals for each individual were compared with signals in the
preexercise sample for each trial, and data were analyzed by
repeated-measures analysis of variance to focus on differences
associated with the intervention rather than differences between
individuals. As shown in Fig. 2,
left, LPL protein in the control trial was increased 8 h after exercise in the control trial. At 22 h after
exercise in the control trial, LPL protein was increased by 170 ± 100% (P < 0.05). The same pattern was seen in the
block trial (Fig. 2, right). At 22 h postexercise, LPL protein content was 240 ± 110% greater than baseline
(P < 0.05) even though exercise was performed in the
setting of both
- and
-blockade.
|
Muscle GLUT-4 protein content.
GLUT-4 protein content was also elevated after exercise bouts in both
the control and block trials (Fig. 3).
GLUT-4 protein content was already elevated 8 h after exercise in
each trial. By 22 h postexercise, GLUT-4 protein content was
increased by 51 ± 16% (P < 0.05) in the control
trial and by 32 ± 6% (P < 0.05) in the block
trial compared with baseline.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Our results confirm that a single bout of exercise increases skeletal muscle LPL protein content (32). Several previous studies have reported the induction of GLUT-4 protein after 7-10 days of endurance exercise (2, 7). A prolonged, single bout of exercise is known to increase skeletal muscle GLUT-4 expression in rats (29). To the best of our knowledge, the present results represent initial data showing that a single bout of exercise also increases GLUT-4 protein in the skeletal muscle of humans.
The present results also provide insight into the mechanisms
underlying the induction of these two proteins that are critical for
normal glucose and lipid metabolism. Catecholamines increase as a
function of exercise intensity (6), and interact with G
protein-coupled adrenergic cell-surface receptors to affect numerous
metabolic pathways. Blocking adrenergic receptors by using
phenoxybenzamine (a nonspecific
-blocker) and propranolol (a
nonspecific
-blocker) during exercise did not prevent the induction
of LPL and GLUT-4 protein in human skeletal muscle. These results
suggest that, even in the absence of stimulation by catecholamines,
skeletal muscle can activate signaling pathways that produce a
coordinated response to ensure fuel acquisition.
At least for LPL, several lines of evidence suggest that catecholamines are involved in the response to exercise. Catecholamines increase cAMP, cAMP levels are increased as a function of exercise or in response to elevated plasma catecholamine concentrations (17, 21), and a cAMP-response element is present in the human LPL promoter (16). Urinary excretion rates of catecholamines account for >80% of the variability in human skeletal muscle LPL activity (22). Infusion of either epinephrine or isoproterenol increases skeletal muscle LPL expression in humans and rodents (3, 4, 27). Catecholamines also increase LPL activity in rat cardiac muscle (5).
The present results suggest that signaling induced by the interaction
between catecholamines and adrenergic receptors is not required for the
exercise-induced increase in LPL protein content. A previous study in
humans concluded that local contractile activity is responsible for
increased LPL activity in muscle (14), but it did not
preclude possible local effects of catecholamines released from nerves
innervating exercising muscles. By using systemic adrenergic-receptor
blockade, our data also show that catecholamines released locally as a
consequence of contractile activity do not play a critical role in LPL
induction. Taken together with a study in rats (8),
available data indicate that muscle contraction itself induces LPL. The
mediator of this effect is unknown, although cAMP is an attractive
candidate. cAMP levels are elevated during exercise even with
-blockade (17, 18).
Studies of the effects of catecholamines on GLUT-4 are less consistent.
Short-term infusion of epinephrine in rats after surgical removal of
the adrenal medulla decreases GLUT-4 transcription (13),
suggesting that catecholamines decrease GLUT-4 expression. Rats
subjected to
-blockade during 6 wk of exercise training show no
increase in muscle GLUT-4, suggesting that catecholamines are necessary
for the exercise-induced increase in GLUT-4 (19). The
present results do not support this interpretation. One possible explanation for this apparent discrepancy is the fact that the rat
study measured GLUT-4
48 h after exercise, a time point at which
adaptive changes in GLUT-4 would be reversed (12).
LPL protein content usually reflects LPL enzyme activity in skeletal muscle (31, 35). Under most circumstances, GLUT-4 protein content reflects the capacity of skeletal muscle to carry out glucose transport (10, 29, 30). Protein levels for LPL and GLUT-4 in the present study are probably elevated because of increased message levels. Previous studies by our laboratory using humans show that an increase in skeletal muscle LPL mRNA precedes an increase in LPL protein after exercise (32). Previous studies by our laboratory using rodents show that exercise induces GLUT-4 mRNA and protein (29). Others have demonstrated an increase in GLUT-4 transcription with exercise (26). Therefore, it is likely that exercise activates a transcriptional signaling pathway independent of adrenergic receptors to increase LPL and GLUT-4 protein. A critical issue is the nature of the signaling pathways that modulate activation of transcription by exercise.
AMPK, activated by energy depletion in muscle, is likely to be involved in the induction of exercise-responsive genes. Growing evidence implicates this kinase in GLUT-4 translocation (9, 20), and recent data indicate that AMPK induces GLUT-4 and hexokinase expression (11). However, the downstream mediators of AMPK are unknown. The mitogen-activated protein kinase pathway may be involved. Muscle contraction is a potent activator of this pathway (1). Mitogen-activated protein kinase may be responsible for the increased transcription of immediate-early genes in skeletal muscle after exercise (34).
Insulin-receptor signaling may also be involved in exercise responses. Skeletal muscle contraction has striking metabolic effects in the absence of insulin (28). Consistent with this notion, exercise increases skeletal muscle glucose transport in muscle-specific insulin-receptor knockout mice (37). However, insulin potentiates the exercise effect in these mice without skeletal muscle insulin receptors, suggesting that perhaps insulin receptors in nonmyocytes or insulin interacting with other receptors can affect exercise responses. In the present study, adrenergic-receptor blockade was associated with lower plasma insulin levels during exercise (Fig. 4A). Adrenergic-receptor signaling has complex effects on insulin secretion and action (38). Because lower insulin levels were seen without differences in plasma glucose (Fig. 4B), adrenergic-receptor blockade may modestly enhance insulin signaling during exercise, at least under the conditions of this experiment.
In summary, a single bout of exercise increases human skeletal muscle
LPL and GLUT-4 protein content in the setting of both
- and
-adrenergic-receptor blockade. Muscle contraction itself, perhaps
acting in response to depletion of high-energy phosphate stores,
appears to mediate fuel acquisition by muscle.
| |
ACKNOWLEDGEMENTS |
|---|
We appreciate the commitment of our study subjects.
| |
FOOTNOTES |
|---|
This work was supported by National Institute of Health (NIH) Grants AG-14658, HL-58427, and DK-53198; by the Washington University General Clinical Research Center (MO1 RR-00036); and by the Washington University Diabetes Research and Training Center (DK-20579). J. S. Greiwe was supported by NIH Institutional National Research Service Award AG-0078.
Address for reprint requests and other correspondence: C. F. Semenkovich, Washington Univ. School of Medicine, 660 S. Euclid Ave., Box 8046, St. Louis, MO 63110 (E-mail semenkov{at}im.wustl.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 11 February 2000; accepted in final form 23 March 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aronson, D,
Violan MA,
Dufresne SD,
Zangen D,
Fielding RA,
and
Goodyear LJ.
Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle.
J Clin Invest
99:
1251-1257,
1997[Web of Science][Medline].
2.
Cox, JH,
Cortright RN,
Dohm GL,
and
Houmard JA.
Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity.
J Appl Physiol
86:
2019-2025,
1999
3.
Deshaies, Y,
Geloen A,
Paulin A,
Marette A,
and
Bukowiecki LJ.
Tissue-specific alterations in lipoprotein lipase activity in the rat after chronic infusion of isoproterenol.
Horm Metab Res
25:
13-16,
1993[Web of Science][Medline].
4.
Eckel, RH,
Jensen DR,
Schlaepfer IR,
and
Yost TJ.
Tissue-specific regulation of lipoprotein lipase by isoproterenol in normal-weight humans.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R1280-R1286,
1996
5.
Friedman, G,
Chajek-Shaul T,
Stein O,
Noe L,
Etienne J,
and
Stein Y.
-Adrenergic stimulation enhances translocation, processing and synthesis of lipoprotein lipase in rat heart cells.
Biochim Biophys Acta
877:
112-120,
1986[Medline].
6.
Greiwe, JS,
Hickner RC,
Shah SD,
Cryer PE,
and
Holloszy JO.
Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training.
J Appl Physiol
86:
531-535,
1999
7.
Gulve, EA,
and
Spina RJ.
Effects of 7-10 days of cycle ergometer exercise on skeletal muscle GLUT-4 protein content.
J Appl Physiol
79:
1562-1566,
1995
8.
Hamilton, MT,
Etienne J,
McClure WC,
Pavey BS,
and
Holloway AK.
Role of local contractile activity and muscle fiber type on LPL regulation during exercise.
Am J Physiol Endocrinol Metab
275:
E1016-E1022,
1998
9.
Hayashi, T,
Hirshman MF,
Kurth EJ,
Winder WW,
and
Goodyear LJ.
Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
Diabetes
47:
1369-1373,
1998[Abstract].
10.
Holloszy, JO,
and
Hansen PA.
Regulation of glucose transport into skeletal muscle.
Rev Physiol Biochem Pharmacol
128:
99-193,
1996[Web of Science][Medline].
11.
Holmes, BF,
Kurth-Kraczek EJ,
and
Winder WW.
Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle.
J Appl Physiol
87:
1990-1995,
1999
12.
Host, HH,
Hansen PA,
Nolte LA,
Chen MM,
and
Holloszy JO.
Rapid reversal of adaptive increases in muscle GLUT-4 and glucose transport capacity after training cessation.
J Appl Physiol
84:
798-802,
1998
13.
Jones, JP,
and
Dohm GL.
Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine.
Am J Physiol Endocrinol Metab
273:
E682-E687,
1997
14.
Kiens, B,
Lithell H,
Mikines KJ,
and
Richter EA.
Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action.
J Clin Invest
84:
1124-1129,
1989.
15.
Kiens, B,
and
Richter EA.
Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans.
Am J Physiol Endocrinol Metab
275:
E332-E337,
1998
16.
Kirchgessner, TG,
Chuat J-C,
Heinzmann C,
Etienne J,
Guilhot S,
Svenson K,
Ameis D,
Pilon C,
D'Auriol L,
Andalibi A,
Schotz MC,
Galibert F,
and
Lusis AJ.
Organization of the human lipoprotein lipase gene and evolution of the lipase gene family.
Proc Natl Acad Sci USA
86:
9647-9651,
1989
17.
Kraus, WE,
Bernard TS,
and
Williams RS.
Interactions between sustained contractile activity and
-adrenergic receptors in regulation of gene expression in skeletal muscles.
Am J Physiol Cell Physiol
256:
C506-C514,
1989
18.
Kraus, WE,
Longabaugh JP,
and
Liggett SB.
Electrical pacing induces adenylyl cyclase in skeletal muscle independent of the
-adrenergic receptor.
Am J Physiol Endocrinol Metab
263:
E226-E230,
1992
19.
Kuo, C-H,
Ding Z,
and
Ivy JL.
Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
Am J Physiol Endocrinol Metab
271:
E847-E854,
1996
20.
Kurth-Kraczek, EJ,
Hirshman MF,
Goodyear LJ,
and
Winder WW.
5' AMP-activated protein kinase activation causes GLUT-4 translocation in skeletal muscle.
Diabetes
48:
1667-1671,
1998[Abstract].
21.
Lee, AD,
Hansen PA,
Schluter J,
Gulve EA,
Gao J,
and
Holloszy JO.
Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle.
Am J Physiol Cell Physiol
273:
C1082-C1087,
1997
22.
Lithell, H,
Cedermark M,
Fröberg J,
Tesch P,
and
Karlsson J.
Increase of lipoprotein lipase activity in skeletal muscle during heavy exercise. Relation to epinephrine excretion.
Metabolism
30:
1130-1134,
1981[Web of Science][Medline].
23.
Ma, Z,
Gingerich RL,
Santiago JV,
Klein S,
Smith CH,
and
Landt M.
Analysis of human plasma leptin by radioimmunoassay.
Clin Chem
42:
942-946,
1996
24.
Marker, JC,
Hirsch IB,
Smith LJ,
Parvin CA,
Holloszy JO,
and
Cryer PE.
Catecholamines in prevention of hypoglycemia during exercise in humans.
Am J Physiol Endocrinol Metab
260:
E705-E712,
1991
25.
Morgan, DR,
and
Lazarow A.
Immunoassay of insulin: two antibody system.
Diabetes
12:
115-126,
1963[Web of Science].
26.
Neufer, PD,
and
Dohm GL.
Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle.
Am J Physiol Cell Physiol
265:
C1597-C1603,
1993
27.
Pedersen, SB,
Bak JF,
Holck P,
Schmitz O,
and
Richelsen B.
Epinephrine stimulates human muscle lipoprotein lipase activity in vivo.
Metabolism
48:
461-464,
1999[Web of Science][Medline].
28.
Ploug, T,
Galbo H,
and
Richter EA.
Increased muscle glucose uptake during contractions: no need for insulin.
Am J Physiol Endocrinol Metab
247:
E726-E731,
1984
29.
Ren, JM,
Semenkovich CF,
Gulve EA,
Gao J,
and
Holloszy JO.
Exercise induces rapid increases in GLUT-4 expression, transport capacity, and insulin-stimulated glycogen storage in muscle.
J Biol Chem
269:
14396-14401,
1994
30.
Ren, JM,
Semenkovich CF,
and
Holloszy JO.
Adaptation of muscle to creatine depletion: effect on GLUT-4 glucose transporter expression.
Am J Physiol Cell Physiol
264:
C146-C150,
1993
31.
Seip, RL,
Angelopoulos TJ,
and
Semenkovich CF.
Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue.
Am J Physiol Endocrinol Metab
268:
E229-E236,
1995
32.
Seip, RL,
Mair K,
Cole TG,
and
Semenkovich CF.
Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient.
Am J Physiol Endocrinol Metab
272:
E255-E261,
1997
33.
Shah, SD,
Clutter WE,
and
Cryer PE.
External and internal standards in the single isotope derivative (radioenzymatic) assay of plasma norepinephrine and epinephrine in normal humans and persons with diabetes mellitus or chronic renal failure.
J Lab Clin Med
106:
624-629,
1985[Web of Science][Medline].
34.
Sherwood, DJ,
Dufresne SD,
Markuns JF,
Cheatham B,
Moller DE,
Aronson D,
and
Goodyear LJ.
Differential regulation of MAP kinase, p70S6K, and Akt by contraction and insulin in rat skeletal muscle.
Am J Physiol Endocrinol Metab
276:
E870-E878,
1999
35.
Simsolo, RB,
Ong JM,
and
Kern PA.
The regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining.
J Clin Invest
92:
2124-2130,
1993.
36.
Sundin, T,
Dahlstrom A,
Norlen L,
and
Svedmyr N.
The sympathetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation.
Invest Urol
14:
322-328,
1977[Web of Science][Medline].
37.
Wojtaszewski, JFP,
Higaki Y,
Hirshman MF,
Michael MD,
Dufresne SD,
Kahn CR,
and
Goodyear LJ.
Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice.
J Clin Invest
104:
1257-1264,
1999[Web of Science][Medline].
38.
Young, JB,
and
Landsberg L.
Catecholamines and the adrenal medulla.
In: Williams Textbook of Endocrinology (9th ed.). Philadelphia, PA: Saunders, 1998, p. 665-728.
This article has been cited by other articles:
![]() |
L. P Turcotte and J. S Fisher Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise Physical Therapy, November 1, 2008; 88(11): 1279 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Green, T. A. Duhamel, G. P. Holloway, J. W. Moule, D. W. Ranney, A. R. Tupling, and J. Ouyang Rapid upregulation of GLUT-4 and MCT-4 expression during 16 h of heavy intermittent cycle exercise Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R594 - R600. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Zhang, L. L. Ji, D. L. Fogt, and V. S. Fretwell Effect of exercise duration on postprandial hypertriglyceridemia in men with metabolic syndrome J Appl Physiol, October 1, 2007; 103(4): 1339 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fontana, D. T. Villareal, E. P. Weiss, S. B. Racette, K. Steger-May, S. Klein, J. O. Holloszy, and and the Washington University School of Medicine C Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E197 - E202. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Burgomaster, N. M. Cermak, S. M. Phillips, C. R. Benton, A. Bonen, and M. J. Gibala Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1970 - R1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Kraniou, D. Cameron-Smith, and M. Hargreaves Acute exercise and GLUT4 expression in human skeletal muscle: influence of exercise intensity J Appl Physiol, September 1, 2006; 101(3): 934 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Kraniou, D. Cameron-Smith, and M. Hargreaves Effect of short-term training on GLUT-4 mRNA and protein expression in human skeletal muscle Exp Physiol, September 1, 2004; 89(5): 559 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. McGee and M. Hargreaves Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle Diabetes, May 1, 2004; 53(5): 1208 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Holloszy A forty-year memoir of research on the regulation of glucose transport into muscle Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E453 - E467. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Zhang, B. Smith, M. M. Langdon, H. L. Messimer, G. Y. Sun, R. H. Cox, M. James-Kracke, and T. R. Thomas Changes in LPLa and reverse cholesterol transport variables during 24-h postexercise period Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E267 - E274. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Booth, M. V. Chakravarthy, S. E. Gordon, and E. E. Spangenburg Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy J Appl Physiol, July 1, 2002; 93(1): 3 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Steensberg, G. van Hall, C. Keller, T. Osada, P. Schjerling, B. Klarlund Pedersen, B. Saltin, and M. A Febbraio Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation J. Physiol., May 15, 2002; 541(1): 273 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Goodpaster, J. He, S. Watkins, and D. E. Kelley Skeletal Muscle Lipid Content and Insulin Resistance: Evidence for a Paradox in Endurance-Trained Athletes J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5755 - 5761. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Greiwe, G. Kwon, M. L. McDaniel, and C. F. Semenkovich Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E466 - E471. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Wadley, R. J. Tunstall, A. Sanigorski, G. R. Collier, M. Hargreaves, and D. Cameron-Smith Differential effects of exercise on insulin-signaling gene expression in human skeletal muscle J Appl Physiol, February 1, 2001; 90(2): 436 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schjerling, M. Hargreaves, D. Cameron-Smith, and Y. Kraniou The Importance of Internal Controls in mRNA Quantification J Appl Physiol, January 1, 2001; 90(1): 401 - 402. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |